BG49408A1 - Medicationad premix - Google Patents

Medicationad premix

Info

Publication number
BG49408A1
BG49408A1 BG8212987A BG8212987A BG49408A1 BG 49408 A1 BG49408 A1 BG 49408A1 BG 8212987 A BG8212987 A BG 8212987A BG 8212987 A BG8212987 A BG 8212987A BG 49408 A1 BG49408 A1 BG 49408A1
Authority
BG
Bulgaria
Prior art keywords
premix
swines
medicationad
tilosine
sulphanilamidopirymidin
Prior art date
Application number
BG8212987A
Inventor
Stojan G Nakov
Lidija T Angelova
Ivan V Popov
Boris G Donev
Liljana P Dancheva
Jordan G Petkov
Original Assignee
Inst Zarneni Khrani I Furazhna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Zarneni Khrani I Furazhna filed Critical Inst Zarneni Khrani I Furazhna
Priority to BG8212987A priority Critical patent/BG49408A1/en
Publication of BG49408A1 publication Critical patent/BG49408A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The premix is intended for prophylactics and therapy of colibacteriosis, eademic disease, salmonella, paratyphus and atropic rhinitis among pigs and swines, as well as of the syndrome mastitis metritis and aglaxy with mother-swines. It reduces the possility for proliferation of a significant number of bacterial infections and the creation of resistant strains of microorganisms. The medicamentose premix contains in weight%: 4,6-dimethyl-2-sulphanilamidopirymidin 0.8 - 1.2, 10% tilosine from 8.0 to 12.0 and N-2-hidroxyethyl-3-methyl-2chinoxalincarboxamid-1,4 dioxide 0.8-1.2.
BG8212987A 1987-12-08 1987-12-08 Medicationad premix BG49408A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG8212987A BG49408A1 (en) 1987-12-08 1987-12-08 Medicationad premix

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG8212987A BG49408A1 (en) 1987-12-08 1987-12-08 Medicationad premix

Publications (1)

Publication Number Publication Date
BG49408A1 true BG49408A1 (en) 1991-11-15

Family

ID=3919835

Family Applications (1)

Application Number Title Priority Date Filing Date
BG8212987A BG49408A1 (en) 1987-12-08 1987-12-08 Medicationad premix

Country Status (1)

Country Link
BG (1) BG49408A1 (en)

Similar Documents

Publication Publication Date Title
ATE87214T1 (en) USE OF CATABOLIC ENZYMES IN THE MANUFACTURE OF A MEDICATION FOR COMBATING ACQUIRED IMMUNE DEFICIENCY (AIDS) AND ITS PRE-STATES (LAS, ARC).
ES2077530A1 (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
CA2189658A1 (en) Controlled-Release Dosage Forms of Azithromycin
NZ291262A (en) E. coli heat-labile enterotoxin derivatives and their use as oral adjuvants
GB8712073D0 (en) Medicament
EP0353581A3 (en) Pharmaceutical compositions comprising selected lactobacillus strains
ES8605375A1 (en) Bacterial preparations and their use.
TR199701490A2 (en) 3-Hydroxypyridine-2-carbon acidamidester and their manufacture.
GR3005768T3 (en)
ES8802209A1 (en) Vaccine system
ES8800160A1 (en) 5,6-Difluoronaphthyridines and 5,6,8-trifluoro-quinolines as antibacterial agents.
ES2112818T1 (en) PHARMACEUTICAL COMPOSITION INCLUDING LACTOBACILLUS PLANTARUM AND ARGININ.
NO179360C (en) Method of Preparing a Fish Vaccine and a Non-Virulent Invasive Mutant Bacterial Strain Contained in the Vaccine
ZA889699B (en) Use of polysulfated heparins
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
BG49408A1 (en) Medicationad premix
ES8607728A1 (en) Drug combinations having synergistic effect
TW365538B (en) Pharmaceutical composition for preventing a bacterial disease of fishes and crustaceans
AP2002002549A0 (en) Attenuated microorganisms for the treatment of infection
EP0286802A3 (en) Use of ofloxacin in treating or preventing locally periodontal disease
GR3026590T3 (en) Antibiotics ge 37468 a, b and c.
IE45136L (en) Rearing of animals
Barrett Significance of oral bacteria in acute leukemia.
Szegli et al. Gram-negative bacterial infection and acute knee joint arthritis.
Gouin et al. Treatment of bronchopulmonary infections with dibekacin.